HPM Partners »

Cytomx Therapeutics shares owned by HPM Partners

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by HPM Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $138k 37k 3.75
2026-03-31 $178k 38k 4.70

More positions owned by HPM Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Us Aggbd Et (AGG)
Procter & Gamble Company (PG)
Eli Lilly & Co. (LLY)

View all positions for HPM Partners

Top funds holding Cytomx Therapeutics

FMR
Kynam Capital Management
BlackRock
Bank of America Corporation
Perceptive Advisors
Vanguard Capital Management
Point72 Asset Management
State Street Corporation
Wellington Management Company
VR Adviser
Baker Bros. Advisors
Geode Capital Management
Elmind Capital
Nextech Invest
Two Sigma Investments

View all funds holding Cytomx Therapeutics